Latest Insider Transactions at Relay Therapeutics, Inc. (RLAY)
This section provides a real-time view of insider transactions for Relay Therapeutics, Inc. (RLAY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Relay Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Relay Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 30
2025
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
17,250
-4.11%
|
$69,000
$4.42 P/Share
|
|
Jan 30
2025
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,791
-5.19%
|
$83,164
$4.42 P/Share
|
|
Jan 30
2025
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
30,823
-4.77%
|
$123,292
$4.42 P/Share
|
|
Jan 30
2025
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
20,791
-4.87%
|
$83,164
$4.42 P/Share
|
|
Jan 29
2025
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
26,541
-5.95%
|
$106,164
$4.55 P/Share
|
|
Jan 29
2025
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,109
-0.52%
|
$8,436
$4.55 P/Share
|
|
Jan 29
2025
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
46,407
-6.69%
|
$185,628
$4.55 P/Share
|
|
Jan 28
2025
|
Peter Rahmer |
BUY
Grant, award, or other acquisition
|
Direct |
139,141
+23.77%
|
-
|
|
Jan 28
2025
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
1,673
-0.54%
|
$6,692
$4.63 P/Share
|
|
Jan 28
2025
|
Thomas Catinazzo Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
139,141
+25.7%
|
-
|
|
Jan 28
2025
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
36,036
-6.07%
|
$144,144
$4.63 P/Share
|
|
Jan 28
2025
|
Donald A Bergstrom President, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
176,400
+20.28%
|
-
|
|
Jan 28
2025
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
3,220
-0.62%
|
$12,880
$4.63 P/Share
|
|
Jan 28
2025
|
Brian Adams Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
139,141
+24.57%
|
-
|
|
Jan 28
2025
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
33,688
-10.47%
|
$134,752
$4.63 P/Share
|
|
Jan 23
2025
|
Sanjiv Patel President and CEO |
SELL
Open market or private sale
|
Indirect |
125,000
-38.52%
|
$500,000
$4.78 P/Share
|
|
Jan 22
2025
|
Sanjiv Patel President and CEO |
SELL
Open market or private sale
|
Indirect |
125,000
-27.81%
|
$500,000
$4.8 P/Share
|
|
Jan 21
2025
|
Sanjiv Patel President and CEO |
SELL
Open market or private sale
|
Indirect |
125,000
-21.76%
|
$500,000
$4.52 P/Share
|
|
Jan 06
2025
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
16,576
-5.1%
|
$66,304
$4.45 P/Share
|
|
Jan 03
2025
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
32,177
-9.0%
|
$128,708
$4.3 P/Share
|
|
Jan 02
2025
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
32,156
-8.25%
|
$128,624
$4.15 P/Share
|
|
Dec 27
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
400
-0.1%
|
$1,600
$4.38 P/Share
|
|
Dec 27
2024
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,865
-0.8%
|
$19,460
$4.4 P/Share
|
|
Dec 27
2024
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
657
-0.13%
|
$2,628
$4.38 P/Share
|
|
Dec 27
2024
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
299
-0.09%
|
$1,196
$4.38 P/Share
|
|
Dec 16
2024
|
Sanjiv Patel President and CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-14.82%
|
$500,000
$5.0 P/Share
|
|
Oct 29
2024
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,300
-0.75%
|
$11,500
$5.95 P/Share
|
|
Oct 28
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
1,621
-0.41%
|
$9,726
$6.06 P/Share
|
|
Oct 28
2024
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,632
-0.5%
|
$9,792
$6.06 P/Share
|
|
Oct 28
2024
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
2,688
-0.51%
|
$16,128
$6.06 P/Share
|
|
Oct 28
2024
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,802
-1.09%
|
$40,812
$6.06 P/Share
|
|
Sep 27
2024
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
295
-0.09%
|
$2,065
$7.51 P/Share
|
|
Sep 27
2024
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
648
-0.12%
|
$4,536
$7.51 P/Share
|
|
Sep 27
2024
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,457
-1.01%
|
$45,199
$7.49 P/Share
|
|
Sep 27
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
245
-0.06%
|
$1,715
$7.51 P/Share
|
|
Jul 31
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
13,708
-3.38%
|
$109,664
$8.19 P/Share
|
|
Jul 30
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
15,128
-3.6%
|
$121,024
$8.28 P/Share
|
|
Jul 29
2024
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,638
-0.5%
|
$13,104
$8.85 P/Share
|
|
Jul 29
2024
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
2,698
-0.51%
|
$21,584
$8.85 P/Share
|
|
Jul 29
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
13,523
-1.56%
|
$108,184
$8.68 P/Share
|
|
Jul 29
2024
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,780
-1.64%
|
$86,240
$8.68 P/Share
|
|
Jul 26
2024
|
Sanjiv Patel President and CEO |
SELL
Open market or private sale
|
Direct |
36,706
-4.57%
|
$330,354
$9.07 P/Share
|
|
Jul 26
2024
|
Sanjiv Patel President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
36,706
+4.37%
|
$183,530
$5.04 P/Share
|
|
Jul 25
2024
|
Sanjiv Patel President and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-6.13%
|
$450,000
$9.16 P/Share
|
|
Jul 25
2024
|
Sanjiv Patel President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+5.77%
|
$250,000
$5.04 P/Share
|
|
Jun 30
2024
|
Peter Rahmer |
BUY
Grant, award, or other acquisition
|
Direct |
2,108
+0.48%
|
$10,540
$5.54 P/Share
|
|
Jun 30
2024
|
Sanjiv Patel President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,108
+0.27%
|
$10,540
$5.54 P/Share
|
|
Jun 27
2024
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,373
-1.38%
|
$56,238
$6.25 P/Share
|
|
Jun 27
2024
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
245
-0.06%
|
$1,470
$6.26 P/Share
|
|
Jun 27
2024
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
648
-0.12%
|
$3,888
$6.26 P/Share
|